SCHEMBL2318641

SCHEMBL2318641

O=P(O)(O)CCCC(CCCP(=O)(O)O)(P(=O)(O)O)P(=O)(O)O

nearest known ligand 0.55

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TYMS P04818 1/20 0.55
GGPS1 O95749 1/20 0.54
LMNA P02545 1/20 0.46
CYP3A4 P08684 1/20 0.46
NFKB1 P19838 1/20 0.46
BLM P54132 1/20 0.46
PMP22 Q01453 1/20 0.46
LPAR3 Q9UBY5 3/20 0.42
LPAR2 Q9HBW0 1/20 0.42
BBOX1 O75936 2/20 0.41
GRM4 Q14833 1/20 0.41
ALDH1A1 P00352 3/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19212014 0.95 GGPS1 (0.56) TYMSGGPS1LMNACYP3A4NFKB1
SCHEMBL2319390 0.92 GGPS1 (0.58) TYMSGGPS1LMNACYP3A4NFKB1
SCHEMBL11347918 0.83 GRM4 (0.50) TYMSGGPS1LMNACYP3A4NFKB1
SCHEMBL10764074 0.79 TYMS (0.55) TYMSLMNACYP3A4NFKB1BLM
SCHEMBL19212012 0.78 GGPS1 (0.39) TYMSGGPS1LMNACYP3A4NFKB1
SCHEMBL19212015 0.78 GGPS1 (0.39) TYMSGGPS1LMNACYP3A4NFKB1
SCHEMBL4413277 0.77 TYMS (0.52) TYMSLMNACYP3A4NFKB1BLM
SCHEMBL19212075 0.77 GGPS1 (0.43) TYMSGGPS1LMNACYP3A4NFKB1
SCHEMBL19212076 0.77 GGPS1 (0.43) TYMSGGPS1LMNACYP3A4NFKB1
SCHEMBL2319103 0.75 TYMS (0.50) TYMSLMNACYP3A4NFKB1BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3413934-B1 IMPROVED TREATMENT OF IMPLANTS WITH PHOSPHONIC ACID COMPOUNDS NANO BRIDGING MOLECULES SA (CH) 2021-10-13 EP claimed
CN-109195641-B Improved implant treatment with phosphonic acid compounds 纳米桥接分子股份公司 2021-07-27 CN claimed
US-11000627-B2 Treatment of implants with phosphonic acid compounds NANO BRIDGING MOLECULES SA (CH) 2021-05-11 US claimed
EP-1698357-B1 POLYPHOSPHONIC ACIDS AND DERIVATIVES THEREOF UNIV GENEVE (CH) 2019-06-26 EP claimed
US-20190038802-A1 IMPROVED TREATMENT OF IMPLANTS WITH PHOSPHONIC ACID COMPOUNDS NANO BRIDGING MOLECULES SA (CH) 2019-02-07 US claimed
EP-3413934-A1 IMPROVED TREATMENT OF IMPLANTS WITH PHOSPHONIC ACID COMPOUNDS Nano Bridging Molecules SA (CH) 2018-12-19 EP claimed
WO-2017137623-A1 IMPROVED TREATMENT OF IMPLANTS WITH PHOSPHONIC ACID COMPOUNDS NANO BRIDGING MOLECULES SA (CH) 2017-08-17 WO claimed
US-9730795-B2 Endosseous implant UNIVERSITE DE GENEVE (CH) 2017-08-15 US claimed
EP-1351722-B2 ENDOSSEOUS IMPLANT UNIV GENEVE (CH) 2016-02-17 EP claimed
US-20140316533-A1 ENDOSSEOUS IMPLANT UNIV GENEVE (CH) 2014-10-23 US claimed
US-7090496-B2 Endosseous implant UNIVERSITE DE GENEVE (CH) 2006-08-15 US claimed
EP-1343545-B1 ENDOSSEOUS IMPLANT UNIV GENEVE (CH) 2006-07-05 EP claimed
EP-1351722-B1 ENDOSSEOUS IMPLANT UNIV GENEVE (CH) 2006-07-05 EP claimed
US-20040054422-A1 Endosseous implant UNIVERSITE DE GENEVE (CH) 2004-03-18 US claimed
US-20040049287-A1 Surface treated with a phosphonic acid, ester, amide or salt; orthopaedic prostheses; bone replacements or reinforcements, dentistry UNIVERSITE DE GENEVE (CH) 2004-03-11 US claimed
EP-1351722-A1 ENDOSSEOUS IMPLANT UNIVERSITE DE GENEVE (CH) 2003-10-15 EP claimed
EP-1343545-A1 ENDOSSEOUS IMPLANT UNIVERSITE DE GENEVE (CH) 2003-09-17 EP claimed
WO-2002040074-A1 ENDOSSEOUS IMPLANT UNIVERSITE DE GENEVE (CH) 2002-05-23 WO claimed
WO-2002040073-A1 ENDOSSEOUS IMPLANT UNIVERSITÉ DE GENÈVE (CH) 2002-05-23 WO claimed
WO-2002040075-A1 ENDOSSEOUS IMPLANT UNIVERSITÉ DE GENÈVE (CH) 2002-05-23 WO claimed